## MTSI: MACOM Technology Solutions Hold - XLK: Technology

### Executive Summary

No thesis match: RSI 70 overbought. Stock is in no-man's land without clear edge. Caution: overbought RSI (70).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($175.66)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Analysts Raised MACOM Targets in November and December on Solid EPS and Sector Tailwinds**
- Source: Yahoo Finance UK | 20251209T080957 | Bullish | Relevance: 99%
- The article discusses why analysts raised targets for MACOM in November and December. This positive outlook is attributed to strong earnings per share (EPS) performance and favorable sector tailwinds.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 12 ($0.02M) |
| Sells | 55 ($206.79M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.4% (+5.9%)
- Blackrock Inc.: 9.4% (+20.8%)
- FMR, LLC: 7.4% (+2.3%)
- T. Rowe Price Invest: 7.3% (+98.9%)
- Invesco Ltd.: 4.6% (+0.1%)

### Key Risks

1. Heavy insider selling: $207M sold (55 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.83 indicates undervaluation relative to growth. Balance sheet: strong liquidity (3.7x). Insider selling cluster ($206.8M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $14.2B |
| Beta | 1.46 |
| 52W Range | $84.00 - $190.95 |
| Short Interest | 4.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.83 |
| Forward P/E | 37.6 |
| Current P/E | 45.0 |
| YoY Growth | 19.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 weakening modestly (-0.9% over 5 days). Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 74th percentile. MRS_5 at 1.6% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.93), confirming momentum. RSI overbought at 70, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.33% (CS: 74) | Strong |
| RSI_14 | 70.1 | Overbought |
| MACD Histogram | 0.93 | Bullish |
| vs SMA20 | 1.101x | Above |
| vs SMA50 | 1.222x | Above |
| vs SMA200 | 1.458x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $189.86
- **Stop Loss:** $175.66 (7.5% risk)
- **Target:** $204.06 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 97
- **Position Value:** $18,416.42
- **Portfolio %:** 18.42%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-05 (Est: $1.00)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.93 | $0.94 | +1.2% |
| 2025Q2 | $0.90 | $0.90 | +0.4% |
| 2025Q1 | $0.84 | $0.85 | +1.1% |
| 2024Q4 | $0.78 | $0.79 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*